Showing results (151-160 of 202) with videos related to

Sort By:
Pageof 21
Nature Reviews. Cancer|May 13, 2024
Cancer therapy with antibodiesSuman Paul, Maximilian F Konig, Drew M Pardoll, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2019
MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial CellsYong Liu, Xianjin Bi, Jiachuan Xiong, et al.
Nanomedicine (London, England)|May 2, 2015
Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxelHirofumi Hanaoka, Takahito Nakajima, Kazuhide Sato, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 5, 2016
Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathwayTing He, Jiachuan Xiong, Ling Nie, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 20, 2019
In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and PotencyRose M Berman, Olivia J Kelada, Nicholas T Gutsche, et al.
Nature Communications|September 22, 2023
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumoursDan Li, Ruixue Wang, Tianyuzhou Liang, et al.
Journal for Immunotherapy of Cancer|April 9, 2021
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular CarcinomaLuan Sun, Fang Gao, Zhanhui Gao, et al.
Molecular Cancer|October 28, 2006
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumorsJennifer A A Gubbels, Jennifer Belisle, Masanori Onda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 23, 2020
IRF-1 promotes renal fibrosis by downregulation of KlothoYan Li, Yong Liu, Yinghui Huang, et al.
Pageof 21